Avacta appoints Francis Wilson as Chief Scientific Officer
Avacta appoints Francis Wilson as Chief Scientific Officer GlobeNewswire February 09, 2026 LONDON and PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION(R), a tumor-activated oncology delivery platform, has appointed Francis Wilson as its Chief Scientific Officer. Since joining Avacta in September 2022 […]